TXG – 10x genomics, inc. (US:NASDAQ)

News

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
1 Momentum Stock to Target This Week and 2 We Turn Down [Yahoo! Finance]
10x Genomics (NASDAQ:TXG) had its price target lowered by analysts at Leerink Partners from $22.00 to $20.00. They now have a "market perform" rating on the stock.
10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026
3 Hyped Up Stocks That Concern Us [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com